Page last updated: 2024-09-05

top 53 and Lung Neoplasms

top 53 has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyagi, K; Kobunai, T; Oh-hara, T; Shibata, J; Sugimoto, Y; Terada, T; Tsuruo, T; Utsugi, T; Wierzba, K; Yamada, Y1
Aoyagi, K; Kobunai, T; Saito, H; Utsugi, T; Wierzba, K; Yamada, Y; Yoshida, M1

Other Studies

2 other study(ies) available for top 53 and Lung Neoplasms

ArticleYear
Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Cancer research, 1996, Jun-15, Volume: 56, Issue:12

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; DNA, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasms, Experimental; Specific Pathogen-Free Organisms; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1996
Specific distribution of TOP-53 to the lung and lung-localized tumor is determined by its interaction with phospholipids.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Etoposide; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Phospholipids; Quinidine; Tissue Distribution

2000